Literature DB >> 22092634

Canine cutaneous perivascular wall tumors at first presentation: clinical behavior and prognostic factors in 55 cases.

D Stefanello1, G Avallone, R Ferrari, P Roccabianca, P Boracchi.   

Abstract

BACKGROUND: Canine cutaneous perivascular wall tumors (c-PWT) are soft tissue sarcomas recently identified when hemangiopericytomas were reclassified. No previous clinical data are available for c-PWT. HYPOTHESIS/
OBJECTIVES: To define the clinical behavior and prognostic role of clinical and pathological variables in a homogeneous population of c-PWT. ANIMALS: Fifty-five c-PWT in 53 client-owned dogs at first presentation undergoing surgery.
METHODS: Retrospective case series. The endpoint was the relapse of tumor (local and/or distant). The prognostic values of clinical (age, sex, weight, site and tumor size, adjuvant therapy) and pathological (status of surgical margins, histological grade, mitosis, percentage of tumor necrosis) variables were investigated by univariate and bivariate analyses (P < .05). The pattern of associations between variables was explored by multivariate correspondence analysis (MCA).
RESULTS: Twelve dogs had a relapse. Ten dogs had local recurrence, 1 had metastatic disease, and 1 had both. The estimated probability of local recurrence was 0.02, 0.08, 0.20, and 0.24 at 6 months, 1, 2, and 3 years, respectively. Size of the tumor was a significant prognostic factor while status of margins had only a clinically relevant hazard ratio. In MCA evaluation, young age, tumor size (< 5 cm), grade I, and location in the extremities were associated. Association was also observed for older age, tumor size (> 5 cm), grade II, and other location. CONCLUSION AND CLINICAL IMPORTANCE: C-PWT tend to locally recur a long time after surgery. An early diagnosis of c-PWT associated with small tumor size (< 5 cm) and clean surgical margins ensures a good prognosis independently of histological grade.
Copyright © 2011 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 22092634     DOI: 10.1111/j.1939-1676.2011.00822.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

Review 1.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

2.  Treatment of canine and feline sarcoma using MR-guided focused ultrasound system.

Authors:  Anastasia Antoniou; Nikolas Evripidou; Stelios Panayiotou; Kyriakos Spanoudes; Christakis Damianou
Journal:  J Ultrasound       Date:  2022-03-12

3.  Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases.

Authors:  Enrico P Spugnini; Bruno Vincenzi; Bruno Amadio; Alfonso Baldi
Journal:  Open Vet J       Date:  2019-03-25

4.  Retrospective study of canine cutaneous tumors submitted to a diagnostic pathology laboratory in Northern Portugal (2014-2020).

Authors:  Irina Amorim; Fátima Gärtner; Ana Luísa Martins; Ana Canadas-Sousa; João R Mesquita; Patrícia Dias-Pereira
Journal:  Canine Med Genet       Date:  2022-02-25

5.  Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?

Authors:  Bernard Séguin
Journal:  Front Oncol       Date:  2017-11-23       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.